chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After getting vaccines including the anthrax shots for going overseas. Redness, seepage, puffiness. Flu like symptoms. One month later I was hospitalized for Bronchitis (in July). I had a number of upper respiratory infections that required outpatient visits for antibiotic treatment. I had feelings of intense agitation, restlessness, & muscle and joint soreness. I had headaches of a different kind than I had had before, migraines, neck & back pain, night sweats, sinus problems, anxiety & severe depression. I also had blood in my stools on a semi regular basis from that point until even today. I had a colonoscopy and was diagnosed with a rectal tag. But the bleeding continued. I began drinking heavily to deaden the pain and lower my anxiety. I voluntarily went into an alcohol rehab program which I failed due to laughing too much and just being silly. I was diagnosed with a self-defeating personality disorder. I was offered an early out with an honorable discharge and took it. After I got out I developed problems standing for long periods of time at work as a cook. I also had an increasing degree of pain thoughout my back from then on. Two years ago, after a minor whiplash accident, I was diagnosed with 9 herniated discs, spinal stenosis, fibromyalgia, arthritis, high blood pressure, high cholesterol, severe ongoing pain, chronic pain syndrome, acid-reflux disease among other problems such as panic attacks, short term memory problems, and severe irritability issues.
Left arm was sore; achy in her lymph nodes; deltoid was hot; deltoid was itchy; rash formed on deltoid, rash to be 102F on her arm; achy in her armpit; chills; Left arm was swollen; Left arm was very red; This spontaneous case was reported by a nurse and describes the occurrence of LYMPH NODE PAIN (achy in her lymph nodes), VACCINATION SITE WARMTH (deltoid was hot), VACCINATION SITE PRURITUS (deltoid was itchy), VACCINATION SITE RASH (rash formed on deltoid, rash to be 102F on her arm) and AXILLARY PAIN (achy in her armpit) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced LYMPH NODE PAIN (achy in her lymph nodes), VACCINATION SITE WARMTH (deltoid was hot), VACCINATION SITE PRURITUS (deltoid was itchy), VACCINATION SITE RASH (rash formed on deltoid, rash to be 102F on her arm), AXILLARY PAIN (achy in her armpit) and CHILLS (chills). On an unknown date, the patient experienced VACCINATION SITE PAIN (Left arm was sore), VACCINATION SITE SWELLING (Left arm was swollen) and VACCINATION SITE ERYTHEMA (Left arm was very red). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, LYMPH NODE PAIN (achy in her lymph nodes), VACCINATION SITE WARMTH (deltoid was hot), VACCINATION SITE PRURITUS (deltoid was itchy), VACCINATION SITE RASH (rash formed on deltoid, rash to be 102F on her arm), AXILLARY PAIN (achy in her armpit), CHILLS (chills), VACCINATION SITE PAIN (Left arm was sore), VACCINATION SITE SWELLING (Left arm was swollen) and VACCINATION SITE ERYTHEMA (Left arm was very red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Cognitive complaints "confusion", "difficulty putting words together", nerve pain, rash, myalgias, polyarthralgia, depressed mood
Patient exhibited symptom of severe heat, swelling, pain and itchiness at and around injection site.
Client presented to clinic with a large reddened area, warm to touch that was 6 cm in diameter on today,12/22/04. Client stated the area had been approximately 12 cm on the left deltoid. NO lesions or broken tissue noted or induration.
administered with vaccine that experienced more than 1 temperature excursion; administered with vaccine that experienced more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (administered with vaccine that experienced more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (administered with vaccine that experienced more than 1 temperature excursion) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 9:39 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 9:39 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (administered with vaccine that experienced more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (administered with vaccine that experienced more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (administered with vaccine that experienced more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (administered with vaccine that experienced more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 60.89.  Concomitant medication of the patient was not reported.  Batch number 030B21A underwent temperature excursion on 03-Apr-2021 with temperature of 34 degree Fahrenheit at 09:00 AM. These vials were moved to fridge on 30-Mar-2021 and beyond use date for the vials was reported as 29-Apr-2021. The vaccines moved to clinic on 03-Apr-2021. Storage condition at the time of the excursion was cooler storage during high-pace COVID-19 vaccination clinic.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination. Vials were only punctured right before administration. Vaccines were not frozen at time of administration and prior to administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. The reporter reported that, no data logger reports were available and fisher brand traceable temperature monitor was used to record hourly temperatures.  No treatment information was provided by the reporter.
ON 3 JUNE 2021 @ 1453, "25-year-old female who presents to the emergency department with 2 days of worsening left-sided chest pain associated with some myalgias shortness of breath she received her second covid vaccination on the first of June.  she also has some bilateral anterior shin pain soreness into her arms as well.  Denied any fever and a productive cough any nausea or diarrhea". Patient was admitted to ICU on 3 June for NSTEMI in setting of chest pain/SOB with elevated TnT. Significant elevation of TnT >3K with unremarkable ECG. TIMI score 1, grace 52. Given her age etiology concerning for possible Myocarditis but will start appropriate tx for NSTEMI and order formal TTE.....Patient has been diagnosed with Myopericarditis. The patient didn't have any significant changes on her EKG, however, she did have elevated troponins up to 3134 ng/L which trended down to 2455 ng/L on recheck.  Given the pleuritic nature of her chest discomfort, MD suspected Acute Myopericarditis.  She is still symptomatic and thus, MD recommended she take high-dose NSAIDs.  MD would not too keen on starting her on steroids and/or colchicine unless she doesn't get better on follow up evaluation.  Echocardiogram showed intact ejection fraction.  MD have sent off additional labs to look for other causes of myopericarditis.  The patient should also be on a low-dose of beta blocker and ACE inhibitor.  She'll follow with her primary care provider and cardiology.
FLU SYMPTOMS (6 HOURS AFTER VACCINATION); LEFT SHOULDER HURT ACUTELY/ SEVER PAIN IN HER SHOULDER; TINGLING WHICH CONTINUED FOR HOURS STARTED ON THE LEFT THEN MOVED TO THE RIGHT; RADIATION WHICH CONTINUED FOR HOURS STARTED ON THE LEFT THEN MOVED TO THE RIGHT; COULD NOT LEFT ARM MORE THAN 45 DEGREES; COULD NOT WORK OUT; BURNING SENSATION WHICH CONTINUED FOR HOURS STARTED ON THE LEFT THEN MOVED TO THE RIGHT; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Healthy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk and expiry: unknown) dose was not reported, administered on 24-AUG-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported On AUG-2021, the patient experienced could not left arm more than 45 degrees. On AUG-2021, the patient experienced could not work out. On AUG-2021, the patient experienced burning sensation which continued for hours started on the left then moved to the right. On AUG-2021, the patient experienced tingling which continued for hours started on the left then moved to the right. On AUG-2021, the patient experienced radiation which continued for hours started on the left then moved to the right.  On 24-AUG-2021, the patient experienced flu symptoms (6 hours after vaccination). On 24-AUG-2021, the patient experienced left shoulder hurt acutely/ sever pain in her shoulder.  Laboratory data included: Body temperature (NR: not provided) 101.2 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu symptoms (6 hours after vaccination), and shaking on 26-AUG-2021, had not recovered from left shoulder hurt acutely/ sever pain in her shoulder, and the outcome of could not left arm more than 45 degrees, could not work out, tingling which continued for hours started on the left then moved to the right, burning sensation which continued for hours started on the left then moved to the right and radiation which continued for hours started on the left then moved to the right was not reported. This report was non-serious.
Within couple of hrs. 02:00PM head sweating and chills that last two days; every join was achy and painful like she had arthritis. Lasted two weeks and dissipated and hyper immunized. The dosage amount might be an issue, since her weight is 85lb height 4ft. 8". Lasted two weeks. Went in to her doctor, Feb. 2021 or March 2021.
Pt was referred from an allergy specialist for vax. Approximately 48 hours post vax, pt developed a severe injection site reaction. The area of induration was 10-15 cm in diameter. It was reported that an empiric anti-staph antibiotic was started with no improvement. He then started outpt therapy with Ancef. The area was reported to exhibit thickening and erythema. At the time of this report, the area was still indurated and peeling. The pt sought medical attention and was hospitalized for treatment of these events on an unspecified date. Follow-up info recvd from an MD indicated that the child was hospitalized for what "looked like a cellulitis." The child had been receiving IV antibiotics for 2 weeks at his home. The MD noted that because he was not the one who administered the vax, he was not sure if the vial was a multi-dose vial or not. Follow-up info recvd from MD indicated that the pt was seen in office on 10/30/01, 3 weeks since the vax and the onset of the cellulitis and fascitis syndrome. The pt had an 8 cm area of induration at the wides diameter of his arm. The MD was going to have the pt continue on the IV antibiotics at home and have another MRI done. Addtl info has been requested. Initial and follow up info has been recieved from a physician concerning an 11 year old male student with a history of periodic fevers who on 10/4/01 was vaccinated in the left upper arm with the first dose (635893/1197K) of pneumococcal vaccine 23 polyvalent upon referral from an allergy specialist for an immunology work-up. Concomitant therapy on 10/4/01 included a dose in the left thigh of diphtheria toxoid/tetanus toxoid. The child's skin eventually desquamated. The physician reported that the IV antibiotics were discontinued on 11/6/01 and that the pt recovered the same day. No further info is available.
I had stay there for 15 minutes, but I felt very tired when I got home. I was itchy on my body. I had a headache. I had those symptoms for a week. I felt very, very tired. I couldn't do anything. Since the vaccine I always feel very weak, and I feel like I have cold symptoms all the time. Three or four times my heart rate is very high.  I feel tired and hard to breathe. I never felt like this before. I feel tachycardia very often.  I have lots of phlegm. I don't have a cold or flu. It's weird. No treatment they said to watch my diet.  From my knees to my feet are in a lot of pain on both sides. I can't even work. I stayed home four day and had to go to Urgent Care. They did lab work, but they have not called me back with the results yet. I went about three weeks. Today at 04:30 I will go back there for the results. They gave me a short, and the pain came down a little but not too much. I tried to soak in warm water and that helped a little, but the pain stayed for almost a week. I have a little pain now in comes in some sharp pains now and that's all nothing constant. It's a little better but not all the way.
Pt. received vaccine at 10.02 am. Pt. arrived to observation area with mother at 10.04 am. Pt. was alert. At 10.17am Pt. stated that his stomach hurt. The mother stated it might be due to his current medical condtions. Th patient wanted to vomit so I provided privacy and gave him a trash can and he vomitted a small amount. I took his vital signs at 10.20 am BP 137/93, oxygen 100%, Pulse 92, Temp was not taken because the patient vommited a small amount. Mother stated that his BP is usually high. At 10.28 am I took another set of vital signs BP 123/88, Oxygen 100%, Pulse 75, Temp 97.2 F. I asked Pt. how he felt and he stated "better".  I advised for the mother andp atient to stay a little longer to take another set of vital signs.. I took the third set at 10.41 am BP 135/95, Temp 97.6 F, Pulse 77, Oxygen 99%. The patient looked fatigued so I called code assist at 10.44 am. The code team  arrived and took over.
aches/pain; little fever; This case was reported by a consumer via call center representative and described the occurrence of pain in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain and fever. On an unknown date, the outcome of the pain and fever were unknown.   It was unknown if the reporter considered the pain and fever to be related to Shingrix.  Additional case details were reported as follows: This case was reported by patient's friends. The age at vaccination was not applicable for this report. Around 20 patients had aches, pain and little fever to Shingrix first or second dose of the vaccine. The patient's friends had stated it looked like if the 2nd dose was given further away from the 1st dose, might be closer to the sixth month the adverse reactions would have been relatively less.  No additional information was provided.  The reporter did not consent to follow-up. This case has been linked with case US2019230500 and US2019230503, reported by same reporter.
rash about a quarter of an inch below the injection site; soreness in the arm; soreness/achiness on her left side; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm), PAIN (soreness/achiness on her left side) and VACCINATION SITE RASH (rash about a quarter of an inch below the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for an unknown indication.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness in the arm) and PAIN (soreness/achiness on her left side). On 07-Mar-2021, the patient experienced VACCINATION SITE RASH (rash about a quarter of an inch below the injection site). On 01-Mar-2021, PAIN IN EXTREMITY (soreness in the arm) and PAIN (soreness/achiness on her left side) had resolved. At the time of the report, VACCINATION SITE RASH (rash about a quarter of an inch below the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
The pt experienced a red raised rash on chest, belly, legs and fingers for 2 days. No fever or other complications.
Small bowel obstruction,  Patient was placed on n.p.o. and IV fluid, patient walked a lot in the hallway.  Last night, patient passed gas, this morning, patient had a diarrhea.  Patient was placed on clear liquid diet and then advanced to full liquid diet, patient had no problem with the diet.  Patient is advised to eat low residue diet for 2 weeks. Patient has DVT on Coumadin, INR was 4.5, patient will hold Coumadin until after she sees someone. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Initial report received on 21 March 2007 from a healthcare professional.  A 54 year old female patent received on 11 October 2006 a dose of Fluzone (lot #U2177AA) and developed generalized hives and raised lump on elbow.  Treated with Benadryl and Tagament.  The event resolved and the patient recovered.  No other vaccines were given concomitantly.  At the time of vaccination the patient had vertigo.  The patient's medical history included multiple environmental life threatening allergies and asthma.  Concomitant medications included ASA, fish oil, sprionolactone, terbutaline prn, Benadryl prn, Singulair, Combavent, and Advair.  The reporter is the same as in case 2007-00863.
I was working and kept feeling pressure under my right rib cage it was very uncomfortable with dull pain. I waited for a few days and I went to the doctor they thought it was reflux, it didn't go away and had a ultrasound and it's still persistent. I kept feeling bloating and the doctor stated it was inflammation in the stomach.
pt recvd adult vax; 3 days later devel a red swollen area @ inject site; approx 3 inches in size;
improperly stored vaccine in use; This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 18-SEP-2020, the patient was vaccinated with improperly stored vaccine, measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot#: T013540 has been verified to be a valid lot number, expiration date 17-OCT-2021, albumin status: rHA (formulation, strength, dose, frequency and route of administration were not reported) for prophylaxis. There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of (6 to 14 Fahrenheit degree (11.7 F)) degrees Fahrenheit for 25 minutes. Data logger was involved. There were no previous excursions reported.
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 24-JUN-2016, the patient was vaccinated with improperly stored doses of GARDASIL 9 (lot # L024993 and expiration date 17-OCT-2017) (strength, dose number, anatomical location and route of administration were not reported). Concomitant therapies were not reported. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Muscle aches in legs, upper back, and neck; Muscle aches in legs, upper back, and neck; Muscle aches in legs, upper back, and neck; slight loss of hearing started approximately 2 hours 15 minutes after receiving vaccine; Ringing/hearing loss then accompanied by an oncoming migraine approximately 10 minutes after the start of the tinnitus; Migraine/headache; Drowsy after 1.5 hours of receiving vaccine; This is spontaneous report from a contactable consumer (patient). A 44-year-old non pregnant female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EW0185 Expiry date unknown) via an unspecified route of administration at right arm on 11Jun2021 08:30 as a single dose for COVID-19 immunization, dose 1 administered at right arm on 19May2021 11:45 (Lot number EW0183 Expiry date unknown) as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. No known allergies were reported. Since the vaccination, the patient had not been tested for COVID-19 and she did not receive any other vaccines within 4 weeks, and she received antibiotics within two weeks of vaccination. On 11Jun2021 10:00 patient felt drowsy after 1.5 hours of receiving vaccine and dissipated after approximately 40 minutes, ringing in right ear accompanied by slight loss of hearing started approximately 2 hours 15 minutes after receiving vaccine, ringing/hearing loss then accompanied by an oncoming migraine approximately 10 minutes after the start of the tinnitus, on 12Jun2021 muscle aches in legs, upper back, and neck. Muscles aches lasted around 3 hours. No further side effects after the muscle aches went away. No further side effects until approximately 20 hours later. Treatment received was Tylenol taken to alleviate the headache before it became worse. Headache and ringing in ear began to dissipate after 15 minutes of taking Tylenol. The outcome of the event slight loss of hearing was recovered on an unknown date in June2021, drowsy after 1.5 hours of receiving vaccine, ringing, migraine/headache was recovered on 11Jun2021 and muscle aches in legs, upper back, and neck recovered on 12Jun2021.
Patient states she woke up this a.m. and bottom lip swollen. States no other swelling noted at this time. Denies any other symptoms. Patient advised to see PCP today and to seek further guidance from PCP before receiving any additional COVID 19 vaccine. Patient voiced understanding.
fever (102.7), sweats, and chills starting about 24 hours after receiving my second dose, but symptoms are declining quickly 24 hours after onset.
swelling 7 redness @ site 6x7 cm 1 wk p/inj; t98.9 treated w/floxin & Decadron